1. Home
  2. Analysis
  3. Accupril
  4. Ionamin

Accupril and Ionamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accupril and Ionamin. Common interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people who take Accupril and Ionamin have. It is created by eHealthMe based on reports of 6 people who take Accupril and Ionamin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

6 people who take Accupril and Ionamin together, and have interactions are studied.

What is Accupril?

Accupril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 13,223 Accupril users for its effectiveness, alternative drugs and more.

What is Ionamin?

Ionamin has active ingredients of phentermine resin complex. It is often used in weight loss. eHealthMe is studying from 2,408 Ionamin users for its effectiveness, alternative drugs and more.

Number of Accupril and Ionamin reports submitted per year:

Accupril and Ionamin drug interactions.

Common Accupril and Ionamin drug interactions by gender *:

female:

  1. Dyspnoea
  2. Chest tightness
  3. Ejection fraction
  4. Fatigue
  5. Mitral valve incompetence
  6. Oedema lower limb
  7. Palpitations
  8. Sweating increased
  9. Abdominal distension
  10. Amnesia

male:

n/a

Common Accupril and Ionamin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Amnesia
  2. Aortic valve incompetence
  3. Arthralgia
  4. Arthritis
  5. Back pain
  6. Blood thyroid stimulating hormone increased
  7. Bradycardia
  8. Bronchitis
  9. Chest pain
  10. Chest tightness

50-59:

  1. Dyspnoea
  2. Aortic valve stenosis
  3. Angina pectoris
  4. Ankle fracture
  5. Aortic valve disease mixed
  6. Aortic valve incompetence
  7. Atrioventricular block
  8. Breath sounds decreased
  9. Cardiovascular disorder
  10. Chest pain

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Accupril and Ionamin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Accupril and Ionamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accupril side effects:

Browse all side effects of Accupril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ionamin side effects:

Browse all side effects of Ionamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Accupril interactions:

Browse all interactions between Accupril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ionamin interactions:

Browse all interactions between Ionamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on quinapril hydrochloride and phentermine resin complex (the active ingredients of Accupril and Ionamin, respectively), and Accupril and Ionamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Accupril and Ionamin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.